Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Rossi

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Neurology|July 2, 2021
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy BodiesMarcello Rossi, Simone Baiardi, Charlotte E Teunissen, et al.
Journal of Medicinal Chemistry|June 25, 2005
Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cellsDaniele Simoni, Giuseppe Giannini, Marinella Roberti, et al.
Journal of Medicinal Chemistry|April 29, 2005
Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporterDaniele Simoni, Marcello Rossi, Valerio Bertolasi, et al.
Acta Neuropathologica|November 22, 2019
Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
Acta Neuropathologica|February 20, 2025
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's diseaseAlexander M Bernhardt, Sebastian Longen, Svenja V Trossbach, et al.
Acta Neuropathologica|July 29, 2021
Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classificationSimone Baiardi, Marcello Rossi, Angela Mammana, et al.
Acta Neuropathologica|October 17, 2019
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
Acta Neuropathologica Communications|October 31, 2021
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodiesKathrin Brockmann, Corinne Quadalti, Stefanie Lerche, et al.
European Journal of Neurology|April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification ProtocolsStefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Journal of Medicinal Chemistry|February 4, 2005
Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell linesDaniele Simoni, Giuseppina Grisolia, Giuseppe Giannini, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Neurology|July 2, 2021
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy BodiesMarcello Rossi, Simone Baiardi, Charlotte E Teunissen, et al.
Journal of Medicinal Chemistry|June 25, 2005
Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cellsDaniele Simoni, Giuseppe Giannini, Marinella Roberti, et al.
Journal of Medicinal Chemistry|April 29, 2005
Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporterDaniele Simoni, Marcello Rossi, Valerio Bertolasi, et al.
Acta Neuropathologica|November 22, 2019
Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
Acta Neuropathologica|February 20, 2025
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's diseaseAlexander M Bernhardt, Sebastian Longen, Svenja V Trossbach, et al.
Acta Neuropathologica|July 29, 2021
Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classificationSimone Baiardi, Marcello Rossi, Angela Mammana, et al.
Acta Neuropathologica|October 17, 2019
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
Acta Neuropathologica Communications|October 31, 2021
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodiesKathrin Brockmann, Corinne Quadalti, Stefanie Lerche, et al.
European Journal of Neurology|April 16, 2025
High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification ProtocolsStefan Bräuer, Maximilian Weber, Christian Deuschle, et al.
Journal of Medicinal Chemistry|February 4, 2005
Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell linesDaniele Simoni, Giuseppina Grisolia, Giuseppe Giannini, et al.
Pageof 8